{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:53:21Z","timestamp":1648749201766},"reference-count":9,"publisher":"BMJ","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Disease in Childhood"],"published-print":{"date-parts":[[1976,12,1]]},"DOI":"10.1136\/adc.51.12.988","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T21:14:24Z","timestamp":1229980464000},"page":"988-988","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of hereditary hypophosphataemic rickets."],"prefix":"10.1136","volume":"51","author":[{"given":"P","family":"Koepp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1126\/science.173.3999.845","article-title":"Serum parathyroid hormone in X-linked hypophosphatemia","volume":"173","author":"Arnaud, C.D.; Glorieux, F.H.; Scriver, C.R.","year":"1971","unstructured":"Arnaud, C. D., Glorieux, F. H., and Scriver, C. R. (1971). Serum parathyroid hormone in X-linked hypophosphatemia. Science, 173, 845.","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/oxfordjournals.qjmed.a067272","article-title":"Hypophosphataemic osteomalacia presenting in adults","volume":"64","author":"Dent, C.E.; Stamp, T.C.B.","year":"1971","unstructured":"Dent, C. E., and Stamp, T. C. B. (1971). Hypophosphataemic osteomalacia presenting in adults. Quarterly Journal of Medicine, 64, 303.","journal-title":"Quarterly Journal of Medicine"},{"key":"ref_3","first-page":"427","article-title":"Treatment of sex-linked hypophosphataemic rickets (SLHR). Clinical Aspects of Metabolic Bone Disease","volume":"270","author":"Dent, C.E.; Round, J.M.; Stamp, T.C.B.","year":"1973","unstructured":"Dent, C. E., Round, J. M., and Stamp, T. C. B. (1973). Treatment of sex-linked hypophosphataemic rickets (SLHR). Clinical Aspects of Metabolic Bone Disease, p. 427. Ed. by B. Frame, A. M. Parfitt, and H. Duncan. International Congress Series No. 270. Excerpta Medica, Amsterdam.","journal-title":"International Congress Series; Excerpta Medica, Amsterdam."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM197209072871003","article-title":"Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia","volume":"287","author":"Glorieux, F.H.; Scriver, C.R.; Reade, T.M.; Goldman, H.; Roseborough, A.","year":"1972","unstructured":"Glorieux, F. H., Scriver, C. R., Reade, T. M., Goldman, H., and Roseborough, A. (1972). Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. New England Journal of Medicine, 287, 481.","journal-title":"New England Journal of Medicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-3476(72)80128-8","article-title":"Acceleration of growth with combined vitamin D-phosphate therapy of hypophosphatemic resistant rickets","volume":"80","author":"McEnery, P.T.; Silverman, F.N.; West, C.E.","year":"1972","unstructured":"McEnery, P. T., Silverman, F. N., and West, C. E. (1972). Acceleration of growth with combined vitamin D-phosphate therapy of hypophosphatemic resistant rickets. Journal of Pediatrics, 80, 763.","journal-title":"Journal of Pediatrics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/archpedi.1965.02090030692013","article-title":"Familial hypophosphatemic vitamin D resistant rickets","volume":"110","author":"Stickler, G.B.; Hayles, A.B.; Rosevear, J.W.","year":"1965","unstructured":"Stickler, G. B., Hayles, A. B., and Rosevear, J. W. (1965). Familial hypophosphatemic vitamin D resistant rickets. American Journal of Diseases of Children, 110, 664.","journal-title":"American Journal of Diseases of Children"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0022-3476(64)80336-X","article-title":"Use of phosphate salts as an adjunct to vitamin D in the treatment of hypophosphatemic vitamin D refractory rickets","volume":"64","author":"West, C.D.; Blanton, J.C.; Silverman, F.N.; Holland, N.H.","year":"1964","unstructured":"West, C. D., Blanton, J. C., Silverman, F. N., and Holland, N. H. (1964). Use of phosphate salts as an adjunct to vitamin D in the treatment of hypophosphatemic vitamin D refractory rickets. Journal of Pediatrics, 64, 469.","journal-title":"Journal of Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00005792-196503000-00001","article-title":"Studies in hypophosphatemic vitamin D-refractory osteomalacia in adults","volume":"44","author":"Wilson, D.R.; York, S.E.; Jaworski, J.F.; Yendt, E.R.","year":"1965","unstructured":"Wilson, D. R., York, S. E., Jaworski, J. F., and Yendt, E. R. (1965). Studies in hypophosphatemic vitamin D-refractory osteomalacia in adults. Medicine, 44, 99.","journal-title":"Medicine"},{"key":"ref_9","first-page":"83","article-title":"In their study","volume":"51","author":"Sir","year":"1976","unstructured":"Sir, In their study Doxiadis et al. (Archives, 1976, 51, 83) conclude that '... in at least some cases of nutritional rickets there is a genetic element which may manifest itself only under adverse environmental conditions'. This explains why only some children with nutritional deficiency may develop rickets, and why only some children treated with phenobarbitone may also develop rickets. 162 children on long-term treatment with phenobarbitone (5 mg\/kg per day) have been observed as outpatients. In 30% of those aged 0-13 years (average duration of treatment 20 months) and in 60%,","journal-title":"Doxiadis et al. (Archives; conclude that '... in at least some cases of nutritional rickets there is a genetic element which may manifest itself only under adverse environmental conditions'. This explains why only some children with nutritional deficiency may develop rickets, and why only some children treated with phenobarbitone may also develop rickets. 162 children on long-term treatment with phenobarbitone (5 mg\/kg per day) have been observed as outpatients. In 30% of those aged 0-13 years (average duration of treatment 20 months) and in 60"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.51.12.988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:06:09Z","timestamp":1601111169000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/adc.51.12.988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1976,12,1]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1976,12,1]]}},"URL":"https:\/\/doi.org\/10.1136\/adc.51.12.988","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[1976,12,1]]}}}